<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31362587</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.</ArticleTitle><Pagination><StartPage>917</StartPage><EndPage>931</EndPage><MedlinePgn>917-931</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2019.1644076</ELocationID><Abstract><AbstractText>Macroautophagy (autophagy) is a key catabolic pathway for the maintenance of proteostasis through constant digestion of selective cargoes. The selectivity of autophagy is mediated by autophagy receptors that recognize and recruit cargoes to autophagosomes. SQSTM1/p62 is a prototype autophagy receptor, which is commonly found in protein aggregates associated with major neurodegenerative diseases. While accumulation of SQSTM1 implicates a disturbance of selective autophagy pathway, the pathogenic mechanism that contributes to impaired autophagy degradation remains poorly characterized. Herein we show that amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD)-linked mutations of <i>TBK1</i> and <i>SQSTM1</i> disrupt selective autophagy and cause neurotoxicity. Our data demonstrates that proteotoxic stress activates serine/threonine kinase TBK1, which coordinates with autophagy kinase ULK1 to promote concerted phosphorylation of autophagy receptor SQSTM1 at the UBA domain and activation of selective autophagy. In contrast, ALS-FTLD-linked mutations of <i>TBK1</i> or <i>SQSTM1</i> reduce SQSTM1 phosphorylation and compromise ubiquitinated cargo binding and clearance. Moreover, disease mutation SQSTM1<sup>G427R</sup> abolishes phosphorylation of Ser351 and impairs KEAP1-SQSTM1 interaction, thus diminishing NFE2L2/Nrf2-targeted gene expression and increasing TARDBP/TDP-43 associated stress granule formation under oxidative stress. Furthermore, expression of SQSTM1<sup>G427R</sup> in neurons impairs dendrite morphology and KEAP1-NFE2L2 signaling. Therefore, our results reveal a mechanism whereby pathogenic SQSTM1 mutants inhibit selective autophagy and disrupt NFE2L2 anti-oxidative stress response underlying the neurotoxicity in ALS-FTLD.<b>Abbreviations:</b> ALS: amyotrophic lateral sclerosis; FTLD: frontotemporal lobar degeneration; G3BP1: GTPase-activating protein (SH3 domain) binding protein 1; GSTM1: glutathione S-transferase, mu 1; HMOX/HO-1: Heme oxygenase 1; IP: immunoprecipitation; KEAP1: kelch-like ECH associated protein 1; KI: kinase inactive; KIR: KEAP1 interaction region; KO: knockout; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MBP: maltose binding protein; NBR1: NBR1, autophagy cargo receptor; NFE2L2/Nrf2: nuclear factor, erythroid derived 2, like 2; NQO1: NAD(P)H quinone dehydrogenase 1; SQSTM1/p62: sequestosome 1; SOD1: superoxide dismutase 1, soluble; S.S.: serum starvation; TARDBP/TDP-43: TAR DNA binding protein; TBK1: TANK binding kinase 1; UBA: <i>ub</i>iquitin <i>a</i>ssociation; ULK1: unc-51 like autophagy activating kinase 1; WT: wild type.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Junghyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cancer Immunology, Genentech Inc, South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purtell</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5242-1390</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palomo</LastName><ForeName>Gloria M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Departments of Structural Biology and Developmental Neurobiology, Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfredi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yanxiang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9408-9979</Identifier><AffiliationInfo><Affiliation>Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Junmin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0472-7648</Identifier><AffiliationInfo><Affiliation>Departments of Structural Biology and Developmental Neurobiology, Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 NS094733</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS060123</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080550" MajorTopicYN="N">Macroautophagy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS-FTLD</Keyword><Keyword MajorTopicYN="N">SQSTM1/p62</Keyword><Keyword MajorTopicYN="N">TBK1</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword><Keyword MajorTopicYN="N">selective autophagy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31362587</ArticleId><ArticleId IdType="pmc">PMC7144840</ArticleId><ArticleId IdType="doi">10.1080/15548627.2019.1644076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Achi EY, Rudnicki SA.. ALS and frontotemporal dysfunction: a review. Neurol Res Int. 2012;2012:806306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3423946</ArticleId><ArticleId IdType="pubmed">22919484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW.. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaele Ferrari DK, Huey ED, Momeni P. FTD and ALS a tale of two diseases. Curr Alzheimer Res. 2011;8(3):273&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJN, Koppers M, et al. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125(6):777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, King OD, Shorter J, et al. Stress granules as crucibles of ALS pathogenesis. J Cell Biol. 2013;201(3):361&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, Lachenmayer ML, Wu S, et al. Proteotoxic stress induces phosphorylation of SQSTM1/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet. 2015;11(2):e1004987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344198</ArticleId><ArticleId IdType="pubmed">25723488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong YC, Holzbaur EL. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci U S A. 2014;111(42):E4439&#x2013;E4448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P, Farhan H, McEwan DG, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333(6039):228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M, Arko-Mensah J, Ponpuak M, et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37(2):223&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B, Sliter DA, Herhaus L, et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A. 2016;113(15):4039&#x2013;4044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Petrovski BNL,S, Sapp PC, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Jin T, Zhu H, et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell. 2018;174(6):1477&#x2013;1491.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore AS, Holzbaur EL. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci U S A. 2016;113(24):E3349&#x2013;E3358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang C, Xu Q, Martin TD, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science. 2015;349(6255):aaa5612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942138</ArticleId><ArticleId IdType="pubmed">26404840</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares JF, Duran A, Reina-Campos M, et al. Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade. Cell Rep. 2015;12(8):1339&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4551582</ArticleId><ArticleId IdType="pubmed">26279575</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Wada K, Okuno M, et al. Serine 403 phosphorylation of SQSTM1/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell. 2011;44(2):279&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">22017874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y, Amari M, Takatama M, et al. Immunoreactivities of SQSTM1, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci. 2006;249(1):13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Nonaka T, Hasegawa M, et al. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for SQSTM1. Neurosci Lett. 2003;342(1&#x2013;2):41&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12727313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiji M, Takahashi T, Fukuba H, et al. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with SQSTM1, but not ubiquitin. Acta Neuropathol. 2008;116(2):183&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">18584184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, Yue Z. Neuronal aggregates: formation, clearance, and spreading. Dev Cell. 2015;32(4):491&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376477</ArticleId><ArticleId IdType="pubmed">25710535</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Purtell K, Lachance V, et al. Autophagy receptors and neurodegenerative diseases. Trends Cell Biol. 2017;27:491&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">28169082</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, et al. Autophagy supports genomic stability by degrading retrotransposon RNA. Nat Commun. 2014;5:5276.</Citation><ArticleIdList><ArticleId IdType="pubmed">25366815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitiprolu M, Jagow C, Tremblay V, et al. A complex of C9ORF72 and SQSTM1 uses arginine methylation to eliminate stress granules by autophagy. Nat Commun. 2018;9(1):2794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052026</ArticleId><ArticleId IdType="pubmed">30022074</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, de Calbiac H, Le Ber I, et al. Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD. Hum Mol Genet. 2015;24(6):1682&#x2013;1690.</Citation><ArticleIdList><ArticleId IdType="pubmed">25410659</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A, Butler K,&#xa0;Long J, et al. Defective recognition of LC3B by mutant SQSTM1/SQSTM1 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy. 2016;12(7):1094&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4990988</ArticleId><ArticleId IdType="pubmed">27158844</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, Korner S, Kiaei M. NFE2L2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int. 2012;2012:878030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3461296</ArticleId><ArticleId IdType="pubmed">23050144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang DD. Mechanistic studies of the NFE2L2-Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">17145701</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-NFE2L2 pathway in stress response and cancer evolution. Genes Cells. 2011;16(2):123&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">21251164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong KI, Kobayashi A, Katsuoka F, et al. Two-site substrate recognition model for the Keap1-NFE2L2 system: a hinge and latch mechanism. Biol Chem. 2006;387(10&#x2013;11):1311&#x2013;1320.</Citation><ArticleIdList><ArticleId IdType="pubmed">17081101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimoto T, Miyazaki K, Morimoto N, et al. Impaired antioxydative Keap1/NFE2L2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res. 2012;1446:109&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">22353756</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M, Kurokawa H, Waguri S, et al. The selective autophagy substrate SQSTM1 activates the stress responsive transcription factor NFE2L2 through inactivation of Keap1. Nat Cell Biol. 2010;12(3):213&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20173742</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A, Rea S, Sultana M, et al. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-NFE2L2 signalling. Mol Cell Neurosci. 2016;76:52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062946</ArticleId><ArticleId IdType="pubmed">27554286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Z, Cao H, Xie X, et al. Phosphatase PP4 negatively regulates type I IFN production and antiviral innate immunity by dephosphorylating and deactivating TBK1. J Immunol. 2015;195(8):3849&#x2013;3857.</Citation><ArticleIdList><ArticleId IdType="pubmed">26363053</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K, Plater L, Peggie M, et al. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem. 2009;284(21):14136&#x2013;14146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682862</ArticleId><ArticleId IdType="pubmed">19307177</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Bieniek KF, Finch N, et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130(1):77&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EY, Longatti A, McKnight NC, et al. Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism. Mol Cell Biol. 2009;29(1):157&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2612494</ArticleId><ArticleId IdType="pubmed">18936157</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner TP, Long J, Layfield R, et al. Impact of SQSTM1/SQSTM1 UBA domain mutations linked to Paget&#x2019;s disease of bone on ubiquitin recognition. Biochemistry. 2011;50(21):4665&#x2013;4674.</Citation><ArticleIdList><ArticleId IdType="pubmed">21517082</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M, Waguri S, Koike M, et al. Homeostatic levels of SQSTM1 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131(6):1149&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, Tan H, Pagala VR, et al. Deep profiling of proteome and phosphoproteome by isobaric labeling, extensive liquid chromatography, and mass spectrometry. Methods Enzymol. 2017;585:377&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441839</ArticleId><ArticleId IdType="pubmed">28109439</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley BE, Kaiser SE, Shaler TA, et al. Ubiquitin accumulation in autophagy-deficient mice is dependent on the NFE2L2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J Cell Biol. 2010;191(3):537&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3003313</ArticleId><ArticleId IdType="pubmed">21041446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura Y, Waguri S, Sou Y-S, et al. Phosphorylation of SQSTM1 activates the Keap1-NFE2L2 pathway during selective autophagy. Mol Cell. 2013;51(5):618&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">24011591</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Zennaro E, Fallini C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111(4):1051&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourriere H, Chebli K, Zekri L, et al. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol. 2003;160(6):823&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173781</ArticleId><ArticleId IdType="pubmed">12642610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kweon JH, Kim S, Lee SB. The cellular basis of dendrite pathology in neurodegenerative diseases. BMB Rep. 2017;50(1):5&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5319658</ArticleId><ArticleId IdType="pubmed">27502014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni VA, Firestein BL. The dendritic tree and brain disorders. Mol Cell Neurosci. 2012;50(1):10&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22465229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SB, Bagley JA, Lee HY, et al. Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in Drosophila. Proc Natl Acad Sci U S A. 2011;108(40):16795&#x2013;16800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3189048</ArticleId><ArticleId IdType="pubmed">21930920</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolz A, Ernst A, Dikic I. Cargo recognition and trafficking in selective autophagy. Nat Cell Biol. 2014;16(6):495&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">24875736</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo YM, Gale M Jr.. Immune signaling by RIG-I-like receptors. Immunity. 2011;34(5):680&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3177755</ArticleId><ArticleId IdType="pubmed">21616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Shimogori T,&#xa0;Hattori N, et al. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through SQSTM1/SQSTM1 phosphorylation. Hum Mol Genet. 2015;24(15):4429&#x2013;4442.</Citation><ArticleIdList><ArticleId IdType="pubmed">25972374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho C-S, Park HW,&#xa0;Ho A, et al. Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1&#x2013;mediated SQSTM1/sequestosome 1 phosphorylation. Hepatology. 2018;68(4):1331-1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6005718</ArticleId><ArticleId IdType="pubmed">29251796</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran T, Bodda C,&#xa0;Krapp C, et al. Attenuation of cGAS&#x2010;STING signaling is mediated by a SQSTM1/SQSTM1&#x2010;dependent autophagy pathway activated by TBK1. Embo J. 2018;37(8):e97858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5897779</ArticleId><ArticleId IdType="pubmed">29496741</ArticleId></ArticleIdList></Reference><Reference><Citation>Korac J, Schaeffer V, Kovacevic I, et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci. 2013;126(Pt 2):580&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3654196</ArticleId><ArticleId IdType="pubmed">23178947</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J, Str&#xf6;m A-L, Kwinter DM, et al. Sequestosome 1/SQSTM1 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J Neurochem. 2009;111(4):1062&#x2013;1073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2766427</ArticleId><ArticleId IdType="pubmed">19765191</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J, Hervias I, Henning MS, et al. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet. 2009;18(23):4552&#x2013;4564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773270</ArticleId><ArticleId IdType="pubmed">19779023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto A, Cremona ML, Rothman JE. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol. 2006;172:719&#x2013;731. PMID: 16505167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063704</ArticleId><ArticleId IdType="pubmed">16505167</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan JA, Ullman E, Dou Z, et al. Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes. Mol Cell Biol. 2011;31(15):3158&#x2013;3170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147612</ArticleId><ArticleId IdType="pubmed">21628531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yang Y, Li Y, et al. Systematic optimization of long gradient chromatography mass spectrometry for deep analysis of brain proteome. J Proteome Res. 2015;14(2):829&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4324436</ArticleId><ArticleId IdType="pubmed">25455107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Li Y, Wu Z, et al. JUMP: a tag-based database search tool for peptide identification with high sensitivity and accuracy. Mol Cell Proteomics. 2014;13(12):3663&#x2013;3673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4256513</ArticleId><ArticleId IdType="pubmed">25202125</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu M, Cho J-H, Kodali K, et al. Extensive peptide fractionation and y(1) ion-based interference detection method for enabling accurate quantification by isobaric labeling and mass spectrometry. Anal Chem. 2017;89(5):2956&#x2013;2963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467445</ArticleId><ArticleId IdType="pubmed">28194965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart E, McEvoy J, Wang H, et al. Identification of therapeutic targets in rhabdomyosarcoma through integrated genomic, epigenomic, and proteomic analyses. Cancer Cell. 2018;34(3):411&#x2013;426.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158019</ArticleId><ArticleId IdType="pubmed">30146332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira TA, Blackman AV, Oyrer J, et al. Neuronal morphometry directly from bitmap images. Nat Methods. 2014;11(10):982&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5271921</ArticleId><ArticleId IdType="pubmed">25264773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>